|
Loại |
Nguồn |
198 |
Tạp chí |
Gayed AA, Kheshary PR, Hinkle RL. Visual compatibility of diltiazem injection with various diluents and medications during simulated Y-site injection. Am J Health-Syst Pharm 1995 ; 52: 516-520. |
336 |
Tạp chí |
Forman JK, Lachs JR, Souney PF. Visual compatibility of acyclovir sodium with commonly used intravenous drugs during simulated Y-site injection. Am J Hosp Pharm 1987 ; 44: 1408-1409. |
385 |
Tạp chí |
Benedict MK, Roche VF, Banakar UV, Hilleman DE. Visual compatibility of amiodarone hydrochloride with various antimicrobial agents during simulated Y-site injection. Am J Hosp Pharm 1988 ; 45: 1117-1118. |
405 |
Tạp chí |
Nieves-Cordero AL, Luciw HM, Souney PF. Compatibility of narcotic analgesic solutions with various antibiotics during simulated Y-site injection. Am J Hosp Pharm 1985 ; 42: 1108-1109. |
406 |
Tạp chí |
Smythe MA, Patel MA, Gasloli RA. Visual compatibility of narcotic analgesics with selected intravenous admixtures. Am J Hosp Pharm 1990 ; 47: 819-820. |
418 |
Tạp chí |
Bosso JA, Townsend RJ. Stability of clindamycin phosphate and ceftizoxime sodium, cefoxitine sodium, cefamandole nafate, or cefazolin sodium in two intravenous solutions. Am J Hosp Pharm 1985 ; 42: 2211-2214. |
472 |
Tạp chí |
Wohlford JG, Fowler MD. Visual compatibility of hetastarch with injectable critical-care drugs. Am J Hosp Pharm 1989 ; 46: 995-996. |
574 |
Tạp chí |
Kleinberg ML, Stauffer GL, Prior RB, Latiolais CJ. Stability of antibiotics frozen and stored in disposable hypodermic syringes. Am J Hosp Pharm 1980 ; 37: 1087-1088. |
576 |
Tạp chí |
Holmes CJ, Ausman RK, Walter CW, Kundsin RB. Activity of antibiotic admixtures subjected to different freeze-thaw treatments. Drug Intell Clin Pharm 1980 ; 14: 353-357. |
604 |
Thông tin của nhà sản xuất |
Stabilité des médicaments dans l'Intermate® SV50, 100, 200 Baxter 1998 |
612 |
Tạp chí |
Frable RA, Klink PR, Engel GL, Mundell EE. Stability of cefamandole nafate injection with parenteral solutions and additives. Am J Hosp Pharm 1982 ; 39: 622-627. |
630 |
Tạp chí |
Das Gupta V, Stewart KR. Stability of metronidazole and ten antibiotics when mixed with magnesium sulphate solutions. J Clin Hosp Pharm 1985 ; 10: 67-72. |
999 |
Tạp chí |
Watson D. Piggyback compatibility of antibiotics with pediatric parenteral nutrition solution. JPEN 1985 ; 9: 220-224. |
1035 |
Tạp chí |
Bisaillon S, Sarrazin R. Compatibility of several antibiotics or hydrocortisone when added to metronidazole solution for intravenous infusion. J Parenter Sci Technol 1983 ; 37: 129-132. |
1047 |
Tạp chí |
Souney PF, Colucci RD, Mariani G, Campbell D. Compatibility of magnesium sulfate solutions with various antibiotics during simulated Y-site injection. Am J Hosp Pharm 1984 ; 41: 323-324. |
1057 |
Tạp chí |
Cutie MR. Compatibility of verapamil hydrochloride injection with commonly used additives. Am J Hosp Pharm 1983 ; 40: 1205-1207. |
1165 |
Tạp chí |
Bowtle WJ, Heasman MJ, Prince AP, Easthope DA. Compatibility of the cephalosporin, cefamandole nafate with injections. Int J Pharm 1980 ; 4: 263-265. |
1201 |
Tạp chí |
Yuhas EM, Lofton FT, Rosenberg HA, Mayron D, Baldinus JG. Cimetidine hydrochloride compatibility III: Room temperature stability in drug admixtures. Am J Hosp Pharm 1981 ; 38: 1919-1922. |
1232 |
Tạp chí |
Beatson C, Taylor A. A physical compatibility study of furosemide & flucloxacillin injections. Br J Pharm Pract 1987 ; 9: 223-226, 236. |
1479 |
Tạp chí |
Digel S. Cefamandolnafat und metronidazol. Chemische stabilität in einer mischung zur intravenösen infusion. Krankenhauspharmazie 1995 ; 1: 9-12. |
3520 |
Thông tin của nhà sản xuất |
Cidomycin - Summary of product Chracteristics. Sanofi 2011 |
3526 |
Thông tin của nhà sản xuất |
Clindamycin (Dalacin®) - Summary of Product Characteristics Pharmacia 2010 |
3546 |
Thông tin của nhà sản xuất |
Cefamandole Flavelab - Résumé des caractéristiques du produit Panpharma SA 2007 |
3549 |
Thông tin của nhà sản xuất |
Amikacine B Braun - Résumé des caractéristiques du produit. B Braun 2012 |
3594 |
Thông tin của nhà sản xuất |
Metronidazole (Flagyl®) - Summary of Product Characteristics Zentiva 2013 |
3643 |
Thông tin của nhà sản xuất |
Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics Sanofi 2015 |
3644 |
Thông tin của nhà sản xuất |
Calcium gluconate® - Summary of Product Characteristics Hameln Pharmaceuticals 2010 |
3674 |
Thông tin của nhà sản xuất |
Erythromycin lactobionate - Summary of Product Characteristics PanPharma 2016 |